Harrow Announces Participation in Upcoming Investor Conferences

HROWL 11.15.2024

Full Press ReleaseSEC FilingsOur HROWL Tweets

About Gravity Analytica

Recent News

  • 01.07.2025 - Harrow Appoints Amir H. Shojaei as Chief Scientific Officer
  • 12.04.2024 - Piper Sandler 36th Annual Healthcare Conference
  • 11.21.2024 - Harrow’s ImprimisRx Subsidiary Receives $34.9 Million Unanimous Jury Verdict Award in ImprimisRx, LLC v. OSRX, Inc.

Recent Filings

  • 01.21.2025 - 8-K Current report
  • 01.08.2025 - 3 Initial statement of beneficial ownership of securities
  • 01.08.2025 - 4 Statement of changes in beneficial ownership of securities
PDF Version

NASHVILLE, Tenn.--(BUSINESS WIRE)--Nov. 15, 2024--Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, today announced that management will participate in the following three investor conferences:

Craig-Hallum 15thAnnualAlpha Select Conference(Sheraton New York Times Square Hotel)November 19, 20241x1 Meetings Only

BTIG 4thAnnual Ophthalmology Day (Virtual)December 2, 20241x1 Virtual Meetings Only

Piper Sandler 36thAnnual Healthcare Conference (The Lotte New York Palace)December 3-5, 2024Company will host a Fireside Chat at8:00 a.m. ETonDecember 4, 2024

The Company will conduct one-on-one meetings at each conference. Investors interested in meeting with management during conferences should contact their representative at each firm to request a meeting. Only the Piper Sandler conference will include an audiowebcast, which will be available on the Company’swebsite.

About HarrowHarrow, Inc.(Nasdaq: HROW) is a leading eyecare pharmaceutical company engaged in the discovery, development, and commercialization of innovative ophthalmic pharmaceutical products for the North American market. Harrow helps eyecare professionals preserve the gift of sight by making its portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of patients each year. For more information about Harrow, please visitharrow.com.

View source version onbusinesswire.com:https://www.businesswire.com/news/home/20241115031085/en/

Jamie Webb, Director of Communications and Investor Relationsjwebb@harrowinc.com615-733-4737

Source:Harrow, Inc.

Please be aware that the following content has been generated by an AI system and may contain errors, inconsistencies, or outdated information. It is provided as-is without any warranties or guarantees of accuracy. We strongly recommend using this content as a starting point for further research and consultation with relevant experts or authorities. We disclaim any liability for damages or losses resulting from the use or reliance on this content.Please note that this is a beta version of the Gravity Analytica LLC’s AI Service which isstill undergoing final testing before its official release. Theplatform, its software and all content found on it are provided on an“as is” and “as available” basis. Gravity Analytica LLC does not give any warranties,whether express or implied, as to the suitability or usability of thisservice, webpage, or its software or any of its content.Should you encounter any bugs, glitches, lack of functionality orother problems on the website, please let us know immediately so wecan rectify these accordingly. Your help in this regard is greatlyappreciated! You can write to us at this addressteam@gravityanalytica.com